Chronic Myeloid Leukemia on Imatinib: Managing Targeted Therapy Side Effects and Quality of Life in Long-Term Treatment
Most people with chronic-phase CML take imatinib for years or even decades. This article covers what the evidence says about managing the most common long-term side effects - nausea, edema, fatigue, and muscle cramps - and why consistent adherence matters as much as the drug itself.
